Jason Valent, MD | oneAMYLOIDOSISvoice

Published: Apr 24, 2019

Tags

Jason Valent is a Hematologist/Oncologist at Cleveland Clinic, Ohio. He completed his graduation from John Carroll University, Ohio USA and medical degree from University of Cincinnati College of Medicine, Ohio USA. Dr. Valent completed his Residency in Internal Medicine from University of Cincinnati Medical Center/University Hospital, Ohio USA followed by Fellowship in Hematology/Oncology from Karmanos Cancer Institute, Detroit, Michigan USA.

Dr. Valent's specialties include diseases & conditions like amyloidosis, cancer, multiple myeloma and rare cancer.

Representative Publications:

Monoclonal gammopathy of undetermined significance: A primary care guide

Ocular Adnexal Amyloidosis: A Mass Spectrometric Analysis

Progress in diagnosing and managing cardiac amyloidosis

Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience

Daratumumab proves safe and highly effective in AL amyloidosis

Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis

Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure

Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy

First Name

Jason